Other OTC - Delayed Quote USD

Healthtech Solutions Inc. (HLTT)

0.0005 -0.0185 (-97.37%)
At close: December 26 at 3:31 PM EST
Loading Chart for HLTT
DELL
  • Previous Close 0.0190
  • Open 0.0005
  • Bid --
  • Ask --
  • Day's Range 0.0005 - 0.0005
  • 52 Week Range 0.0005 - 0.2480
  • Volume 20,000
  • Avg. Volume 0
  • Market Cap (intraday) 48,066
  • Beta (5Y Monthly) 2.57
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0400
  • Earnings Date May 16, 2024 - May 20, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Healthtech Solutions Inc., through its subsidiaries, operates as a life sciences company. It focuses on the development of wound care products for acute and chronic wounds, including a placental membrane allograft for burns and non-healing wounds, such as diabetic foot ulcers. The company also engages in the development of ultrasound imaging and artificial intelligence-based image analysis software for the applications in treatment of chest and musculoskeletal system. In addition, it is developing software technology that compares a healthy heart rhythm electronic signal with a damaged heart's signal that derives an electronic signal representing the curative waveform. Healthtech Solutions Inc. was founded in 2018 and is based in Tuckahoe, New York.

18

Full Time Employees

December 31

Fiscal Year Ends

Recent News: HLTT

Performance Overview: HLTT

Trailing total returns as of 5/17/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

HLTT
0.00%
S&P 500
11.18%

1-Year Return

HLTT
99.59%
S&P 500
29.04%

3-Year Return

HLTT
99.95%
S&P 500
27.06%

5-Year Return

HLTT
96.67%
S&P 500
84.38%

Compare To: HLTT

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: HLTT

Valuation Measures

Annual
As of 3/25/2024
  • Market Cap

    48.06k

  • Enterprise Value

    3.32M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.02

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    1.97

  • Enterprise Value/EBITDA

    -0.98

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -180.34%

  • Return on Assets (ttm)

    -136.09%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    1.69M

  • Net Income Avi to Common (ttm)

    -3.04M

  • Diluted EPS (ttm)

    -0.0400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    97.59k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -1.57M

Research Analysis: HLTT

Company Insights: HLTT

Research Reports: HLTT